Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Import Bill Shifts Burden To FDA; Rep. Dingell Opposes, Citing PDMA

Executive Summary

The House-passed "Drug Importation Fairness Act" will place "unrealistic burdens" on FDA, Rep. Klink (D-Penn.) maintained during floor debate June 28.

You may also be interested in...



Pfizer Has New Michigan Representative: Dingell Wins House Primary

Energy & Commerce Committee Ranking Democrat John Dingell is likely to return to Washington in 2003 with Pfizer as a constituent following his victory in the Aug. 6 Michigan primaries

Pfizer Has New Michigan Representative: Dingell Wins House Primary

Energy & Commerce Committee Ranking Democrat John Dingell is likely to return to Washington in 2003 with Pfizer as a constituent following his victory in the Aug. 6 Michigan primaries

FDA Personal Use Drug Import Policy Being Examined By Reps. Tauzin, Dingell

The House Energy & Commerce Committee wants FDA, the Customs Service and the Drug Enforcement Administration to provide a list of all controlled substances brought into the U.S. under FDA's "personal use" exemption import policy.

Related Content

UsernamePublicRestriction

Register

PS036299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel